These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2375008

  • 1. [Maximal therapy of hypercholesterolemia in coronary heart disease].
    Thiery J, Armstrong V, Bosch T, Eisenhauer T, Schuff-Werner P, Seidel D.
    Ther Umsch; 1990 Jun; 47(6):520-9. PubMed ID: 2375008
    [Abstract] [Full Text] [Related]

  • 2. [Maximal treatment of hypercholesteremia: what is possible?].
    Thiery J.
    Arzneimittelforschung; 1990 Mar; 40(3A):383-8. PubMed ID: 2185771
    [Abstract] [Full Text] [Related]

  • 3. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
    Thiery J, Seidel D.
    Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
    [Abstract] [Full Text] [Related]

  • 4. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up].
    Wenke K, Thiery J, Meiser B, Arndtz N, Seidel D, Reichart B.
    Z Kardiol; 1995 Feb; 84(2):130-6. PubMed ID: 7717016
    [Abstract] [Full Text] [Related]

  • 5. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
    Ghizzoni G, Rusconi C, Faggiano P, Sabatini T, Oneglia C, Gardini A.
    Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811
    [Abstract] [Full Text] [Related]

  • 6. Treatment of hypercholesterolemia and prevention of coronary artery disease after heart transplantation by combination of low-dose simvastatin and HELP-LDL-apheresis.
    Wenke K, Thiery J, Arndtz N, Meiser BM, Seidel D, Reichart B.
    Transplant Proc; 1992 Dec; 24(6):2674-6. PubMed ID: 1465897
    [No Abstract] [Full Text] [Related]

  • 7. Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation.
    Jaeger BR, Meiser B, Nagel D, Uberfuhr P, Thiery J, Brandl U, Brückner W, von Scheidt W, Kreuzer E, Steinbeck G, Reichart B, Seidel D.
    Circulation; 1997 Nov 04; 96(9 Suppl):II-154-8. PubMed ID: 9386091
    [Abstract] [Full Text] [Related]

  • 8. [Clinical long-term results of H.E.L.P.-apheresis].
    Schuff-Werner P.
    Z Kardiol; 2003 Nov 04; 92(Suppl 3):III28-9. PubMed ID: 14663598
    [Abstract] [Full Text] [Related]

  • 9. [Hypercholesterolemia: therapeutic approach].
    Alessandri C, Peverini F.
    Clin Ter; 1991 Jun 30; 137(6):373-97. PubMed ID: 1832610
    [Abstract] [Full Text] [Related]

  • 10. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
    Geiss HC, Otto C, Parhofer KG.
    Metabolism; 2006 May 30; 55(5):599-604. PubMed ID: 16631435
    [Abstract] [Full Text] [Related]

  • 11. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS, Bacon SP, Illingworth DR.
    J Lab Clin Med; 2003 Apr 30; 141(4):250-6. PubMed ID: 12677170
    [Abstract] [Full Text] [Related]

  • 12. [Statins in primary prevention of coronary heart disease].
    Paulweber B.
    Wien Med Wochenschr; 1999 Apr 30; 149(5-6):129-38. PubMed ID: 10408004
    [Abstract] [Full Text] [Related]

  • 13. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 30; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.
    Kroon AA, van Asten WN, Stalenhoef AF.
    Ann Intern Med; 1996 Dec 15; 125(12):945-54. PubMed ID: 8967704
    [Abstract] [Full Text] [Related]

  • 16. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T.
    Clin Ther; 2007 Nov 15; 29(11):2419-32. PubMed ID: 18158082
    [Abstract] [Full Text] [Related]

  • 17. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
    Elam MB, Cushman W, Applegate WB, Heimberg M.
    Tenn Med; 1997 May 15; 90(5):189-92. PubMed ID: 9130876
    [No Abstract] [Full Text] [Related]

  • 18. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA.
    Int J Cardiol; 2005 Oct 10; 104(3):338-45. PubMed ID: 16186066
    [Abstract] [Full Text] [Related]

  • 19. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS, Mikhailidis DP.
    Curr Med Res Opin; 2006 Mar 10; 22(3):511-28. PubMed ID: 16574035
    [Abstract] [Full Text] [Related]

  • 20. [Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia].
    Tomei R, Rossi L, Carbonieri E, Franceschini L, Cemin C, Ghebremariam-Tesfau K, Zardini P.
    Cardiologia; 1993 Dec 10; 38(12):773-8. PubMed ID: 8200011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.